四川科伦药业股份有限公司 关于中期票据获准注册的公告

Core Viewpoint - Sichuan Kelun Pharmaceutical Co., Ltd. has received approval for the registration of its medium-term notes, indicating a strategic move to raise funds based on market conditions and financial needs [1]. Group 1 - The company's proposal for issuing non-financial corporate debt financing instruments was approved by the board on April 22, 2025, and subsequently by the annual general meeting on May 19, 2025 [1]. - The company received the acceptance notice from the China Interbank Market Dealers Association on September 16, 2025, confirming the registration of its medium-term notes [1]. - The company plans to issue the notes in phases according to its funding requirements and market conditions, committing to timely information disclosure [1].